CTRA vs KAPA · P/E 15, rev $7.64B vs $18.8M cap
Coterra Energy Inc (CTRA) versus Kairos Pharma, Ltd. (KAPA) — a side-by-side from cached financials, not a winner call.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Kairos Pharma, Ltd. (KAPA) is a biotechnology company listed on US.
Latest reported CTRA revenue for 2025-12-31 was $7.64B. Net income was $1.72B. Revenue was up 40.1% from 2024-12-31 to 2025-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
KAPA does not have a complete income-statement cache yet.
CTRA currently screens at market cap $20.46B and trailing P/E 15.2. KAPA currently screens at market cap $18.8M.
Not investment advice. Open the CTRA and KAPA stock pages for the full models.
Not investment advice.